Lonza

We are delighted to announce that Francois Ricard, Global Head of R&D at Lonza, will be presenting at CMAC Open Days 2025 on 18th March, with a session titled "Science to Solutions: Reshaping CMC through Partnerships". In his talk, Francois will discuss how strategic collaborations and enabling technologies are accelerating drug development, optimizing CMC processes, and driving pharmaceutical innovation. If you want to connect with Francois Ricard after the presentation, make sure to join the event. You can register here: CMAC | Open Days 2025

Join us at the Advanced Therapies Congress in London Next Week! We’re excited to be part of Terrapinn’s Advanced Therapies Congress, where our experts will take stage to deliver insightful presentations on advancing cell & gene therapy: 📌Keynote Presentation | Fatma Aybegum Senkesen 🎤Driving Advances to Expand the Adoption of Cell & Gene Therapies 📌Viral Vector Manufacturing Track Presentation | Peng Wang, Ph.D. 🔬 Industrialization of AAV Manufacturing by Xcite® Transient and Stable Production Platforms If you’re attending, connect with our team and schedule a meeting in advance via the congress’s partnering platform: https://lnkd.in/gBZjdrk. See you in London! #GeneTherapy #CellTherapy #AAV #LonzaCGT #RealizingPotentialTogether

Milan, innovation, and new opportunities—BIO-Europe Spring is just around the corner! From March 17-19, we’ll be at Booth 25, ready to connect with biotech and pharma leaders who are shaping the future of medicine. We look forward to seeing you there!

We’re proud to announce that Lonza has been named among the World’s Most Ethical Companies for 2025 by Ethisphere. This marks the fourth time that we have been honored with this award, which celebrates our commitment to merging performance with integrity and accountability. The award involves a comprehensive and robust review of our company’s governance, leadership and reputation, environmental and societal impact, ethics and compliance program, and overall commitment to business ethics. Lonza is one of two companies headquartered in Switzerland and one of three companies in the pharmaceutical industry to be included in the 2025 honorees. #Lonza #Ethics #Compliance #Integrity 

We have announced today a collaboration with Exogenus Therapeutics to develop Exo-101, Exogenus’ exosome-based lead candidate. Exo-101 has been shown to have regenerative, anti‑inflammatory and immunomodulatory properties in multiple preclinical models and is expected to reach patients in 2027. Under the agreement, Lonza will leverage its expertise in exosome development and analytical services from its Siena site in Italy and dedicate a team of experts to define a GMP-compliant process for Exo-101 production. Read more here: https://lnkd.in/dvRZaECd #Lonza #Exosomes #Biotechnology #PharmaceuticalManufacturing

In just one week, Lonza will present at this year’s DCAT (Drug, Chemical & Associated Technologies Association) Member Company Announcement Forum during DCAT Week on: “Investing in our global CDMO network - Building the broadest set of modalities, technologies and scales”. Stefan Egli, current Head of the Mammalian Business Unit, will discuss our recent acquisitions and expansions in Vacaville, Visp, and Stein—highlighting how these investments strengthen Lonza’s integrated, end-to-end offering and enhance supply chain security for our customers. Additionally, he will share insights on strategic co-investments with our customers and how he plans to continue fostering these collaborations in his upcoming role as Head of Strategic Enterprise Accounts. 📅 Interested in attending? Register here: https://lnkd.in/e9W9BGHq 💬 Want to discuss this with our team? Schedule a meeting here: https://lnkd.in/dCi_y7Db #DCATWeek #DCATCompanyMemeberAnnouncementForum #MakingtheMedicinesofTomorrow #DCATWeek2025 #OneLonza 

For International Women's Day, we asked our colleagues how mentoring can empower development and enrich careers. Our global mentoring program is designed bring together colleagues to build relationships, gain confidence and remove barriers for women in the workplace. #IWD25 #InternationalWomensDay #AccelerateAction #Mentorship #AMeaningfulDifference

Unlock the secrets of successful oral solid dosage (OSD) manufacturing tech transfers! Join Lonza's experts, Rebecca Peek PMP, MSBE, and Laura Treche on 11th March to gain insights into process validation, regulatory requirements, and Lonza's advanced equipment capabilities.   Discover strategies for streamlining your tech transfers whilst ensuring consistent quality and operational efficiency. Register now! https://lnkd.in/dEvQJdD9   #LonzaSM #OSDManufacturing #TechTransfers

Today we announced that Lonza Capsules & Health Ingredients has established a Center of Applied Sustainability to accelerate sustainability efforts. Comprised of a dedicated team of experts, the Center will drive forward Lonza CHI’s sustainability strategy by implementing solutions to reduce its footprint in line with Lonza’s near-term science-based emissions reduction targets, validated by the Science Based Targets initiative (SBTi). The Center will also provide end-to-end support for customers seeking to reduce their emissions, from upstream supply chain emissions to downstream low environmental impact products. Read more here: https://lnkd.in/dxa6E8RB #Lonza #Capsules #Sustainability #ESG #PharmaceuticalManufacturing

Explore a cutting-edge approach to acid reflux management! Learn how linaprazan glurate could provide longer-lasting relief than traditional PPIs, and why it matters for those living with chronic gastroesophageal reflux disease. Listen here, or wherever you usually find your podcasts: https://lnkd.in/gu2XXsnZ #AcidReflux #GERD #PharmaceuticalManufacturing #Lonza #Podcast #AViewOn